Ganoderma lucidum, commonly referred to as reishi or lingzhi mushrooms, are edible mushrooms with potential health benefits. Extracts and spore powder of Ganoderma lucidum have been shown to lower cardiovascular disease (CVD) risk factors and reduce oxidative stress levels, offering potential solutions.

A meta-analysis of RCTs identified modest effects of Ganoderma lucidum supplementation on several health indices. Subgroup analyses demonstrated how dosage, age at intervention and duration all impacted outcomes.

It is made from ganoderma fungus and coffee

Ganoderma coffee is a drink crafted by mixing classic coffee with Ganoderma fungus to produce an antioxidant and active ingredient-rich beverage that has positive health benefits for the body. It boasts a distinctive taste and should be enjoyed throughout the day for optimal performance. Also popularly known for its medicinal benefits and weight-loss capabilities, hemp seed offers many essential vitamins, minerals and amino acids – helping prevent dementia and Alzheimer’s disease as well as improving blood circulation, reducing inflammation and increasing brain activity. Coffee bean extract helps the stomach function properly and improve digestion, promote fat and sugar metabolism, lower blood pressure and decrease risk for cardiovascular diseases. Furthermore, this drink can improve blood pressure as well as decrease risk. The recipe calls for roast coffee beans soaked in water with Ganoderma Fungus powder added as ingredients. Blended coffee drinks offer an exquisite, unique experience that can be served hot or cold and enjoyed anytime of day. A medium-dark roast provides strong aroma and flavor; bitterness may be reduced by adding milk.

Coffee has long been consumed as a beverage that stimulates both mind and body. It provides energy while stimulating lipid and protein synthesis to aid weight loss; also reduces heart disease risk through lower cholesterol levels; provides mental stimulation through improving memory; stimulates sensitive thinking processes; helps treat migraines and respiratory ailments, among many other things.

Ganoderma lucidum (Lingzhi) has long been esteemed in traditional Asian medicine and more recently Western medical practice. The fungus, often referred to as “reishi” or “lingzhi,” may possess anti-aging and immunomodulatory properties; yet clinical trials on supplementing with Lingzhi have yielded mixed results; meta-analyses of 17 RCTs suggest it has moderate impacts on BMI, creatinine levels, and GPx but does not alter blood pressure, triglycerides levels HDL levels HDL levels or inflammation markers such as hs-CRP or TNF-a levels.

It can help you lose weight

Reishi Coffee (Latin: Ganoderma Lucidum) is an invigorating drink made by combining the benefits of Reishi Mushrooms and classic Coffee together for maximum health benefits. Reishi Coffee can help maintain a healthy weight by improving immunity while providing antioxidants and other essential nutrients to the body. Reishi coffee should be drunk regularly – its positive impact can be felt within weeks while long-term consumption will enhance health benefits and even help prevent diseases!

This research sought to systematically assess the nutritional and therapeutic effects of G. lucidum by conducting an exhaustive systematic review and dose-response meta-analysis of RCTs. Results demonstrated that supplementing with Ganoderma had significant impacts on BMI, creatinine levels, GPx activity levels in at-risk and healthy populations alike; it had minimal effects on other cardiovascular measures such as blood glucose, lipid profiles, or inflammatory markers.

To perform our meta-analysis, we searched MEDLINE (via PubMed), Cochrane Library, EMBASE and Web of Science databases for human participants randomized either Ganoderma lucidum or control groups randomized randomized clinical trials (RCTs) conducted using RCT designs with direct health-related outcomes reported, without restrictions of language, publication year or participant age. Animal/in vitro studies or publications that did not report effect sizes of interventions were excluded from consideration for analysis.

Pooled analysis included 17 RCTs, with an average participant age of 26.3 years and quality assessed using GRADE framework as very low for all outcome measures.

This meta-analysis revealed several notable findings. Ganoderma lucidum supplementation significantly improved BMI, creatinine, glutathione peroxidase levels, GPx activity and heart rate among at-risk and generally healthy populations, but had no noticeable impact on other cardiometabolic parameters like triglycerides, HDL-C or LDL-C levels. Subgroup analysis by health condition dosage duration indicated its effects were greatest among at-risk individuals versus healthy ones.

It can help you maintain a healthy weight

Ganoderma lucidum supplementation appears to have modest effects on BMI, creatinine levels, GPx activity levels and heart rate but no significant influence on blood pressure (BP), lipid profiles or inflammatory markers. Due to low quality evidence available at present, recommendations cannot be given at this time; more research must be conducted into its long-term effectiveness and optimal dose for use. It is also essential that interactions occur with various medications or foods which could alter its absorption, bioavailability or pharmacokinetics properties.

Numerous studies have demonstrated the therapeutic efficacy of mushroom extracts found in ganoderma coffee for cardiovascular disease treatment, but trials conducted are usually small with limited sample sizes and lack rigorous methodology or randomization, leading to considerable uncertainties in conclusions drawn. Furthermore, most have been conducted under an indirect blind review condition which introduces bias into findings; as a result it is essential to conduct additional clinical trials with larger sample sizes and more stringent methods.

Ganoderma spores were recently shown to reduce both total cholesterol (TC) and triglyceride (TG) levels in diabetic rats, mitigating oxidative stress by upregulating genes associated with fat metabolism and improving beta oxidation of fatty acids. Furthermore, their effect was seen through increases in ACOX1 gene expression which indicated greater beta-oxidation of fatty acids.

This meta-analysis of 17 RCTs suggests Ganoderma lucidum has modest effects on key health indices, including BMI, creatinine levels and glutathione peroxidase activity; however it had no significant impacts on weight, blood pressure, fasting glucose, HDL-C levels or fasting glucose. Subgroup analyses however demonstrated significant increases in TC and creatinine as well as MDA improvements for participants under 50 years of age.

Overall, the meta-analysis found that Ganoderma lucidum significantly improved BMI and TC in individuals at risk for chronic diseases or generally healthy people, but had no discernible impact on weight, DBP, SBP, fasting glucose, HDL-C or TG levels. Unfortunately, its quality of evidence rating was very low due to poor methodology in included trials; future trials should address these limitations by using more robust approaches, such as prospective and multicenter designs with standard methodologies, large sample sizes with appropriate participant selection criteria as well as protocols that establish blinding, allocation concealment or dropout protocols.

It can help you control your blood sugar

Ganoderma has been widely recognized as having anti-diabetic properties and helping maintain healthy lipid profiles, yet few clinical studies have examined its efficacy in humans. Unfortunately, those that have explored its effects often used small sample sizes with inconsistent methodologies and variable supplement formulations; hence the results may not be conclusive. A greater understanding of molecular mechanisms underlying Ganoderma’s hypoglycemic properties will allow further trials to confirm these findings.

Eugenol extracted from Ganoderma lucidum has been shown to improve glucose tolerance, reduce blood glucose and cholesterol levels, increase insulin sensitivity in diabetic rats and reduce oxidative stress and inflammation by activating GABA receptors, which regulate ion channels and neurotransmitters. These benefits have been attributed to inhibiting hepatic gluconeogenesis and phosphorylating AMPK; additionally it reduced oxidative stress through activating GABA receptors that control neurotransmitter regulation as well as reduce oxidative stress via activating GABA receptor activation which in turn reduced oxidative stress and inflammation due to activation of GABA receptors that regulate ion channels and neurotransmitters regulation by activation of GABA receptors that participates in neurotransmitter regulation by activated GABA receptors which were involved in their effecting activation.

Recent meta-analyses of 17 RCTs reported modest yet consistent effects of Ganoderma lucidum supplementation on BMI, creatinine levels and glutathione peroxidase concentration in at-risk but generally healthy populations; however supplementation had no noticeable impacts on BP, lipid profiles or inflammatory markers; this could be related to limited bioavailability, trial duration issues or ceiling effects in individuals who already had normal baseline values.

Ganoderma, known for its hypoglycemic activity, has also been reported to protect against oxidative damage and improve cardiovascular health in those with diabetes. This may be attributed to its ability to block the formation of advanced glycation end products (AGEs) and reactive oxygen species which cause vascular damage (Sargowo et al 2022a). Furthermore, Ganoderma could help stop accumulation of triglycerides and lipoproteins in liver tissue by inhibiting formation of these harmful molecules (Sargowo 2022a).

Fifteen clinical studies using Ganoderma are currently ongoing; however, most have either stopped recruiting or remain unknown in status. Five ongoing trials focus on conditions like eczema, uveitis, prostate cancer and lung cancer; these Phase III/IV trials should include larger sample sizes with specific inclusion/exclusion criteria as well as established standards and blinding. Furthermore, more advanced methodologies could measure cellular physiology and metabolic processes to more precisely and validly evaluate Ganoderma’s effects on body.